Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Vitagliano, A
Youve tried every diet
Because metabolic response varies from person to person, these visits are essential for determining whether the current dose is appropriate or should be adjusted
If more than 5 days have passed, skip the missed dose and resume your regular weekly schedule on your next scheduled day
THNR tracks the VettaFi Weight Loss Drug & Treatment Index, which specifically targets companies engaged in the research, development, and manufacturing of GLP-1 agonists and their alternatives
as of 2026 lands in these ranges: Semaglutide (Wegovy): $1,100 to $1,400 per month at retail Tirzepatide (Zepbound): $1,000 to $1,300 per month at retail Sermorelin (compounded): $200 to $400 per month at a licensed clinic CJC-1295 + Ipamorelin (compounded): $250 to $450 per month Insurance coverage for Wegovy and Zepbound has improved in 2026 but remains inconsistent
US$ 21.23
US$ 29.57
US$ 25.51
US$ 22.74
US$ 23.45
US$ 21.89
US$ 27.24
US$ 21.26
US$ 28.40
US$ 20.00
